Physician profile
Todd B Tescher
NPI 1669498028
$1,469.33
in general payments reported to CMS, 2019-2025
22 companies · $46.28 in 2025
The $46.28 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $353 · 2021: $118 · 2022: $59.65 · 2023: $213 · 2024: $187 · 2025: $46.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $349.76 | 2019-2024 | Myrbetriq |
| Karl Storz Endoscopy-America | $275.79 | 2020 | |
| Pfizer INC. | $122.81 | 2019-2023 | |
| Amgen INC. | $107.73 | 2019-2024 | Prolia, Evenity |
| Teleflex LLC | $84.12 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $68.62 | 2019-2023 | Erleada |
| Urogen Pharma, INC. | $62.66 | 2023-2025 | Jelmyto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.31 | 2019-2023 | Jardiance |
| Endo Pharmaceuticals INC. | $45.74 | 2019 | |
| Laborie Medical Technologies Corp. | $45.26 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $43.90 | 2023-2025 | Speedicath |
| Photocure INC | $29.11 | 2021-2022 | |
| Novo Nordisk INC | $27.31 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $21.50 | 2023 | Gemtesa |
| Urovant Sciences INC | $19.93 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.62 | 2019 | |
| Tactile Systems Technology INC | $17.47 | 2023 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $17.45 | 2024 | Farxiga |
| Merck Sharp & Dohme LLC | $16.74 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $15.63 | 2023 | Bard Urinary Drainage Bag |
| Zyla Life Sciences, INC. | $13.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Tescher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.